These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 11448923

  • 1. Treatment of meningeal breast cancer xenografts in the rat using an anti-p185/HER2 antibody.
    Bergman I, Barmada MA, Griffin JA, Slamon DJ.
    Clin Cancer Res; 2001 Jul; 7(7):2050-6. PubMed ID: 11448923
    [Abstract] [Full Text] [Related]

  • 2. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ.
    Oncogene; 1998 Oct 29; 17(17):2235-49. PubMed ID: 9811454
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F, Leadon SA, Yu Y, Boyer CM, O'Briant K, Ward K, McWatters A, Zhao X, Bae DS, DeSombre K, Zalutsky MR, Bast RC.
    Clin Cancer Res; 2000 Aug 29; 6(8):3334-41. PubMed ID: 10955821
    [Abstract] [Full Text] [Related]

  • 5. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
    Roh H, Pippin J, Boswell C, Drebin JA.
    J Surg Res; 1998 Jun 29; 77(1):85-90. PubMed ID: 9698539
    [Abstract] [Full Text] [Related]

  • 6. Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
    Brodowicz T, Kandioler D, Tomek S, Ludwig C, Rudas M, Kunstfeld R, Koestler W, Hejna M, Budinsky A, Wiltschke C, Zielinski CC.
    Br J Cancer; 2001 Nov 30; 85(11):1764-70. PubMed ID: 11742500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity].
    Lu H, Qin H, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2000 Sep 30; 22(5):370-3. PubMed ID: 11778270
    [Abstract] [Full Text] [Related]

  • 11. AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu.
    Masuda K, Richter M, Song X, Berezov A, Masuda K, Murali R, Greene MI, Zhang H.
    Oncogene; 2006 Dec 14; 25(59):7740-6. PubMed ID: 16785990
    [Abstract] [Full Text] [Related]

  • 12. Induction of adaptive Anti-HER2/neu immune responses in a Phase 1B/2 trial of 2B1 bispecific murine monoclonal antibody in metastatic breast cancer (E3194): a trial coordinated by the Eastern Cooperative Oncology Group.
    Borghaei H, Alpaugh RK, Bernardo P, Palazzo IE, Dutcher JP, Venkatraj U, Wood WC, Goldstein L, Weiner LM.
    J Immunother; 2007 Dec 14; 30(4):455-67. PubMed ID: 17457220
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D, Press O.
    Cancer Res; 1992 Apr 01; 52(7):1916-23. PubMed ID: 1348016
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Control of breast tumor cell growth using a targeted cysteine protease inhibitor.
    Xing R, Wu F, Mason RW.
    Cancer Res; 1998 Mar 01; 58(5):904-9. PubMed ID: 9500448
    [Abstract] [Full Text] [Related]

  • 20. Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines.
    Boente MP, Berchuck A, Whitaker RS, Kalén A, Xu FJ, Clarke-Pearson DL, Bell RM, Bast RC.
    Gynecol Oncol; 1998 Jul 01; 70(1):49-55. PubMed ID: 9698473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.